Syracuse, NYNCT07309445Now EnrollingIRB Ready

Non-Muscle Invasive Bladder Neoplasms Clinical Trial in Syracuse, NY

Access cutting-edge non-muscle invasive bladder neoplasms treatment through this clinical trial at a research site in Syracuse. Study-provided care at no cost to qualified participants.

Sponsored by Janssen Research & Development, LLC

Quick Self-Assessment

See if you qualify for this Syracuse location

Preparing your pre-screening questions…

Expert Care in Syracuse

Access non-muscle invasive bladder neoplasms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-muscle invasive bladder neoplasms treatment provided free

Apply for This Syracuse Location

Check if you qualify for this non-muscle invasive bladder neoplasms clinical trial in Syracuse, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Syracuse

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Syracuse site if eligible
  4. 4Begin participation

About This Non-Muscle Invasive Bladder Neoplasms Study in Syracuse

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer occur again (disease-free survival) in participants with non-muscle invasive bladder cancer (NMIBC; an early-stage bladder cancer that is limited to the inner lining of bladder).

Sponsor: Janssen Research & Development, LLC

Who Can Participate

Inclusion Criteria

Has a confirmed diagnosis of NMIBC based on TURBT or cold cup biopsy
Initiated first dose of TAR-200 in a real-world setting within 6 weeks prior to baseline visit/Study visit 1
Participants with childbearing potential are required to adhere to contraceptive recommendations as specified in the approved product labeling for TAR-200. Additionally, participants should seek consultation with their physician for personalized contraceptive advice
Must provide informed consent as described in the protocol

Exclusion Criteria

Has any medical condition deemed by the health care practitioner (HCP) as contraindicated to receive TAR-200 treatment
Had previous treatment with TAR-200 discontinued prior to baseline visit/Study visit 1
Previously received TAR-200 intravesically as part of a clinical trial(s)
Previously received greater than (\>) 2 doses/cycles of TAR-200 in the real-world setting
Currently participating in an interventional bladder cancer clinical trial

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Syracuse?

Yes, this clinical trial (NCT07309445) has an active research site in Syracuse, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Muscle Invasive Bladder Neoplasms Treatment Options in Syracuse, NY

If you're searching for non-muscle invasive bladder neoplasms treatment options in Syracuse, NY, this clinical trial (NCT07309445) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Syracuse research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-muscle invasive bladder neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-muscle invasive bladder neoplasms clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Syracuse, NY

See all alzheimers disease clinical trials recruiting in Syracuse — not just this study.

Browse Alzheimers Disease Trials in Syracuse

Ready to Join in Syracuse?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Syracuse, NY